Qian Fenglei Restructures Capital Market with "FO-X" Strategy: Acquires 600 Million HKD Stake to Take Control of WellCell, Aiming for Trillion-Dollar Web3 Ecosystem
HONG KONG, May 9, 2025 /PRNewswire/ -- When traditional capital meets the Web3.0 wave, a disruptive capital experiment is quietly unfolding in Hong Kong's stock market. On May 9, 2025, WellCell (02477.HK), a Hong Kong-listed company, announced that...
BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy
CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of...
Registration Open: CBD Guangzhou 2025 to Showcase Innovation in Building Decoration with 'Three-Ecology' Strategy
GUANGZHOU, China, March 26, 2025 /PRNewswire/ -- The 27th China (Guangzhou) International Building Decoration Fair (CBD Guangzhou 2025) is set to take place from July 8-11, 2025, at the Canton Fair Complex and Poly World Trade Expo Center (PWTC) in...
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1, a self-developed and...
